
Okeron 0.1mg Injection
Marketer
Wockhardt Ltd
Salt Composition
Octreotide acetate (0.1mg)
Overview Okeron 0.1mg Injection
Octreotide 0.1mg injection treats acromegaly, carcinoid tumors, and bleeding esophageal varices, and helps prevent post-pancreatic surgery complications. Administration is exclusively by a healthcare provider; self-injection is contraindicated. Dosage and frequency are determined by your physician. Consistent use is crucial for optimal therapeutic effect; discontinue only under medical supervision. Common side effects include diarrhea, abdominal pain, nausea, constipation, gas, and headache. Report persistent or worsening side effects. Prior to treatment, disclose any liver conditions and all other medications you are currently using.
Uses of Okeron 0.1mg Injection
Overgrowth of tissues (acromegaly), carcinoid cancers, and esophageal variceal hemorrhage.
Major Benefits of Okeron 0.1mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Okeron 0.1mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Okeron 0.1mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
How Okeron 0.1mg Injection works:
Okeron 0.1mg Injection mimics the action of somatostatin, a naturally occurring human hormone regulator. This medication reduces the activity of several hormones, including growth hormone, and minimizes esophageal bleeding via vasoconstriction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Okeron 0.1mg Injection is undetermined. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Okeron (0.1mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Okeron 0.1mg Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Okeron 0.1mg Injection.
KidneySAFE IF PRESCRIBED
Okeron 0.1mg Injection presents no safety concerns for patients with renal impairment; dosage modification is unnecessary.
LiverCAUTION
Administering Okeron 0.1mg Injection requires careful consideration in individuals with hepatic impairment. Dosage modification for Okeron 0.1mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Okeron 0.1mg Injection :
Should you forget a dose of Okeron 0.1mg Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Okeron 0.1mg Injection
| Label | Value |
|---|---|
| Chemical Type | Somatostatin Analogs |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Action Class | Somatostatin analogs |
